TARGETING THE FRIGHT OF MULTIPLE SCLEROSIS IN PREGNANCY
Multiple Sclerosis (MS) is a chronic inflammatory disease of central nervous system characterised by autoimmune demyelination and scarring of myelin sheath of axons of brain and spinal cord. With high predilection for females (2.5:1) especially so in active reproductive age it has concern with pregnancy and post-partum outcomes. The institution of disease modifying drugs (DMD) during pregnancy with its long term benefits bears some controversy. A bidirectional interrelationship exists between MS and pregnancy. Although MS does no affect fertility but may complicate the pregnancy with preeclampsia, miscarriage, ectopic pregnancy or even prolonged labour requiring close monitoring of such patients. Whereas other auto immune diseases for ex. Rheumatoid arthritis, pregnancy is typically stabilizing period in the clinical course of MS except for small issues like fatiguability, insomnia etc. Thus generally there are no ill effects from pregnancy towards MS.